Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion

Kidney International

Volumn 56, Issue 2, 1999, Pages 601-611

  Persy, Veerle P ^a   Verstrepen, Walter A ^a   Ysebaert, Dirk K ^a   De Greef, Kathleen E ^a   De Broe, Marc E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acute renal failure; Cell adhesion; Ischemia; Necrosis; Phosphoprotein; Regeneration; Renal injury

Indexed keywords

OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; TISSUE REPAIR;

EID: 0032774599     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00581.x     Document Type: Article

References (46)

1. 1. BRADY HR, SINGER GG: Acute renal failure. Lancet 346:1533-1540, 1995
2. 2. DUBOSE TD, WARNOCK DG, MEHTA RL, BONVENTRE JV, HAMMERMAN MR, MOLITORIS BA, PALLER MS, SIEGEL NJ, SCHERBENSKE J, STRIKER GE: Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am J Kidney Dis 29:793-799, 1997
3. 3. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
4. 4. VENKATACHALAM MA, BERNARD DB, DONOHUE JF, LEVINSKY NG: Ischemic damage and repair in the rat proximal tubule: Differences among the S1, S2 and S3 segments. Kidney Int 14:31-49, 1978
5. 5. YSEBAERT DK, DE GREEF KE, VERCAUTEREN SR, GHIELLI M, NOUWEN EJ, EYSKENS EJ, DE BROE ME: Leukocyte infiltration in relation to damage and regeneration of the rat kidney after severe warm ischemia/reperfusion injury. J Am Soc Nephrol (in press)
6. 6. TAKADA M, NADEAU KC, SHAW GD, MARQUETTE KA, TILNEY NL: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: Inhibition by a soluble P-selectin ligand. J Clin Invest 99:2682-2690, 1997
7. 7. TOBACK FG: Regeneration after acute tubular necrosis. Kidney Int 41:226-246, 1992
8. 8. WITGALL R, BROWN D, SCHWARTZ C, BONVENTRE J: Localization of proliferating nuclear antigen, vimentin, c-fos and clusterin in postischemic kidney: Evidence for a heterogenous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93:2175-2188, 1994
9. 9. VAN DIJK S, D'ERRICO JA, SOMERMAN MJ, FARACH-CARSON MC, BUTLER WT: Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J Bone Miner Res 12:1499-1506, 1993
10. 10. BUTLER WT: The nature and significance of osteopontin. Connect Tissue Res 23:123-126, 1989
11. 11. DENHARDT DT, NODA M: Osteopontin expression and function: Role in bone remodeling. J Cell Biochem 30/31(Suppl):92-102, 1998
12. 12. OATES AJ, BARRACLOUGH R, RUDLAND PS: The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 17:1-15, 1997
13. 13. GIACHELLI CM, BAE N, ALMEIDA M, DENHARDT DT, ALPERS CE, SCHWARTZ SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696, 1993
14. 14. LIAW L, ALMEIDA M, HART CE, SCHWARTZ SM, GIACHELLI CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224, 1994
15. 15. LIAW L, BIRK DE, BALLAS CB, WHITSITT JS, DAVIDSON JM, HOGAN LM: Altered wound healing in mice lacking a functional osteopontin gene. J Clin Invest 101(Suppl 1):1468-1478, 1998
16. 16. HOYER JR, OTVOS L, URGE L: Osteopontin in urinary stone formation. Ann NY Acad Sci 760:257-265, 1995
17. 17. SHIRAGA H, MIN W, VANDUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR, FOREMAN JW, PRZYSIECKI C, NEILSON EG, HOYER JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the asparlic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430, 1992
18. 18. ASPLIN JR, ARSENAULT D, PARKS JH, COE FL, HOYER JR: Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194-199, 1998
19. 19. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
20. 20. YOUNG BA, BURDMANN EA, JOHNSON RJ, ALPERS CE, GIACHELLI CM, ANG E, ANDOH T, BENNETT WM, COUSER WG: Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439-448, 1995
21. 21. PICHLER R, GIACHELLI CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
22. 22. MAGIL AB, PICHLER RH, JOHNSON RJ: Osteopontin in chronic puromycin aminonucleoside nephrosis. J Am Soc Nephrol 8:1383-1390, 1997
23. 23. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int 47:1546-1557, 1995
24. 24. KLEINMAN JG, WORCESTER EM, BESHENSKY AM, SHERIDAN AM, BONVENTRE JV, BROWN D: Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 760:321-323, 1995
25. 25. PADANILAM BJ, MARTIN DR, HAMMERMAN MR: Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137:2133-2140, 1996
26. 26. FINN WF, FERNANDEZ-REPOLLET E, GOLDFARB D, IAINA A, ELIAHOU E: Attenuation of injury due to unilateral renal ischemia: Delayed effects of contralateral nephrectomy. J Lab Clin Med 103:193-203, 1984
27. 27. FRIED TA, HISHIDA A, BARNES JL, STEIN JH: Ischemic acute renal failure in the rat: Protective effect of uninephrectomy. Am J Physiol 247:F568-F574, 1984
28. 28. LIAW L, ALMEIDA M, HART CE, SCHWARTZ SM, GIACHELLI CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224, 1994
29. 29. TISHER CC, MADSEN KM: Anatomy of the kidney, in The Kidney (vol 1, 3rd ed), edited by BRENNER BM, RECTOR FC, Philadelphia, Ardmore Medical Books, 1986, pp 3-54
30. 30. MADSEN KM, ZHANG L, ABU SHAMAT A-R, SIEGFRIED S, CHA J-H:Ultrastructural localisation of osteopontin in the kidney: Induction by lipopolysaccharide. J Am Soc Nephrol 8:1043-1053, 1997
31. 31. KLEINMAN JG, BESHENSKY A, WORCESTER EM, BROWN D: Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585-1596, 1995
32. 32. NEMIR M, DE VOUGE MW, MUKHERJEE BB: Normal rat kidney cells secrete both phosphorylated and non-phosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 264:18202-18208, 1989
33. 33. SINGH K, DE VOUGE MW, MUKHERJEE BB: Physiological properties and differential glycosylation of phosphorylated and non-phosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 265:18696-18701, 1990
34. 34. SINGH K, MUKHERJEE AB, DE VOUGE MW, MUKHERJEE BB: Differential processing of osteopontin transcripts in rat kidney-and osteoblast-derived cell lines. J Biol Chem 267:23847-23851, 1992
35. 35. SENGER DR, PERRUZZI CA, PAPADOPOULOS-SERGIOU A, VAN DE WATER L: Adhesive properties of osteopontin: Regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5:565-574, 1994
36. 36. LIAW L, SKINNER MP, RAINES EW, ROSS R, CHERESH DA, SCHWARTZ SM, GIACHELLI CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 95:713-724, 1995
37. 37. XUAN JW, HOTA C, SHIGEYAMA Y, D'ERRICO JA, SOMERMAN MJ, CHAMBERS AF: Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J Cell Biochem 57:680-690, 1995
38. 38. GAILIT J, COLFLESH D, RABINER I, SIMONE J, GOLIGORSKY MS: Redistribution and dysfunction of integrins in cultured renal epithelial cells exposed to oxidalive stress. Am J Physiol 264:F149-F157, 1993
39. 39. MOLITORIS BA: Ischemia-induced loss of epithelial polarity: Potential role of the actin cytoskeleton. Am J Physiol 260:F769-F778, 1991
40. 40. NOIRI E, GAILIT J, SHETH D, MAGAZINE H, GURRATH M, MULLER G, KESSLER H, GOLIGORSKY MS: Cyclic RGD peplides ameliorate ischemic acute renal failure in rats. Kidney Int 46:1050-1058, 1994
41. 41. KANETO H, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Osteopontin expression in the kidney during unilateral ureteral obstruction. Miner Electrolyte Metab 24:227-237, 1998
42. 42. HWANG SM, LOPEZ CA, HECK DE, GARDNER CR, LASKIN DL, LASKIN JD, DENHARDT DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715, 1994
43. 43. ROLLO EE, LASKIN DL, DENHARDT DT: Osteopontin inhibits nitric oxide production and cytoloxicity by activated RAW264.7 macrophages. J Leukoc Biol 60:397-404, 1996
44. 44. PERESLENI T, NOIRI E, GOLIGORSKY MS: Antisense oligodeoxy-necleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol 270:F971-F977, 1996
45. 45. YING W-Z, SANDERS PW: Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Kidney Int 54:1150-1156, 1998
46. 46. NOUWEN EJ, VERSTREPEN WA, BUYSSENS N, ZHU M-Q, DE BROE ME: Hyperplasia, hypertrophy and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 70:479-493, 1994